ADAMS AND REESE, LLP

Lobbying for ORCA BIO · Development of high-precision cell therapies for treating cancer and autoimmune disease

Filing Registration

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Apr 28, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

California

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Assist client with federal legislative governmental relations

Budget/Appropriations

Assist client with federal legislative governmental relations

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.